Followers | 2768 |
Posts | 77901 |
Boards Moderated | 1 |
Alias Born | 05/10/2007 |
Thursday, October 13, 2016 8:53:18 AM
Recent OCUL News
- Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024 • GlobeNewswire Inc. • 09/25/2024 11:30:00 AM
- Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/12/2024 08:05:00 PM
- Ocular Therapeutix™ to Present at September Retina Meetings • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Ocular Therapeutix™ to Present at Two Investor Conferences in September • GlobeNewswire Inc. • 09/04/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:08:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 09:17:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/27/2024 08:18:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 09:10:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 08:36:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/21/2024 09:32:38 PM
- Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/09/2024 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/07/2024 08:15:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 11:23:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:13:30 AM
- Ocular Therapeutix™ Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 08/07/2024 11:10:00 AM
- Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study in Wet AMD • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:30:50 PM
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 • GlobeNewswire Inc. • 07/31/2024 11:30:00 AM
- Ocular Therapeutix™ Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 10:41:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 10:40:11 PM
- Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/18/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/17/2024 08:19:24 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM